论文部分内容阅读
Ｓｕｍｉｔｏｍｏ Ｐｈａｒｍａ公司的多巴胺Ｄ２／５－ＨＴ２拮抗剂哌罗匹隆（ｐｅｒｏｓｐｉｒｏｎｅ，Ｌｕｌｌａｎ）在日本首次上市，用于治疗精神分裂症。 本品推荐起始剂量为一日３次，每次４ｍｇ，可增加至最大日剂量４８ｍｇ。４ｍｇ片剂的补偿价为每片２７日元（合０
Sumitomo Pharma’s dopamine D2 / 5-HT2 antagonist, perospirone (Lullan), was first marketed in Japan for the treatment of schizophrenia. This product is recommended starting dose 3 times a day, each 4mg, can increase to the maximum daily dose of 48mg. The compensation price of 4 mg tablets is 27 yen per tablet (together 0